Pharmacy-supported transition-of-care interventions significantly reduced the odds of 30-day all-cause readmissions compared with usual care (OR 0.68; 95% CI 0.61-0.75).
Meta-Analysis (n=61,858)
Do pharmacy-supported transition-of-care interventions reduce 30-day all-cause readmissions in adult patients discharged to home?
Pharmacy-supported transition-of-care programs are associated with a significant 32% reduction in the odds of 30-day all-cause readmissions for adults discharged to home.
Estimación del efecto: OR 0.68 (95% CI 0.61-0.75)
Objective: To describe pharmacy-supported transition-of-care (TOC) interventions and determine their effect on 30-day all-cause readmissions. Data Sources: MEDLINE/PubMed, EMBASE, International Pharmaceutical Abstracts, ABI Inform Complete, PsychINFO, Web of Science, Academic Search Complete, CINHAL, Cochrane library, OIASTER, ProQuest Dissertations 95% CI = 0.61 to 0.75) observed for pharmacy-supported TOC interventions compared with usual care. Heterogeneity was identified ( I 2 = 55%; P < 0.001). A stratified meta-analysis showed that interventions with patient-centered follow-up reduced 30-day readmissions relative to studies without follow-up (OR = 0.70; CI = 0.63 to 0.78). Conclusions: Pharmacy-supported TOC programs were associated with a significant reduction in the odds of 30-day readmissions.
Rodrigues et al. (Fri,) conducted a meta-analysis in Hospital discharge (n=61,858). Pharmacy-supported transition-of-care interventions vs. Usual care was evaluated on 30-day all-cause readmissions (OR 0.68, 95% CI 0.61-0.75). Pharmacy-supported transition-of-care interventions significantly reduced the odds of 30-day all-cause readmissions compared with usual care (OR 0.68; 95% CI 0.61-0.75).